Wandercraft

Wandercraft, a French startup founded in 2012, received a significant €40.00M Series C investment on 20 January 2022 from Bpifrance, XAnge, AG2R La Mondiale, Euazeo, LBO France, Malakoff Humanis, Quadrant Management, Sofiouest, Mutuelles Impact, Cemag Invest. The company's mission is to provide an ordinary life to extraordinary people by making wheelchair users walk again through the development of autonomous exoskeletons. Their flagship product, Atalante, has enabled patients to walk over 2 million steps, bringing smiles to the faces of 546 individuals. Wandercraft's innovative approach to robotics and healthcare has positioned them as a leader in the industry. The company collaborates with top-tier university labs and medical centers in Europe and the US, further solidifying its status as a pioneer in the field of robotic exoskeletons. The company's inclusive and supportive work environment, as well as its dedication to creating life-changing technology, make Wandercraft an appealing investment opportunity. With a focus on impacting the health and happiness of mobility-impaired individuals, Wandercraft's groundbreaking work continues to make a significant difference in the lives of millions.